← Back to Screener
SkinHealth Systems Inc. Class A Common Stock (SKIN)
Price$0.61
Value ScoreA
Growth ScoreD
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-66.87%
Price vs S&P 500 (4W)4.77%
VGM Score46.01
Market Capitalization$78.74M
All Metrics
P/CF (Annual)2.10x
Book Value / Share (Quarterly)$0.43
P/TBV (Annual)7.01x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-6.32%
Cash Flow / Share (Quarterly)$0.18
Price vs S&P 500 (YTD)-64.45%
Gross Margin (TTM)67.35%
Net Profit Margin (TTM)-2.04%
EPS (TTM)$-0.06
10-Day Avg Trading Volume1.31M
EPS Excl Extra (TTM)$-0.06
Revenue Growth (5Y)20.36%
EPS (Annual)$-0.08
ROI (Annual)-2.24%
Gross Margin (Annual)67.68%
Net Profit Margin (5Y Avg)-33.82%
Cash / Share (Quarterly)$1.58
Revenue Growth QoQ (YoY)-6.71%
ROA (Last FY)-1.90%
Revenue Growth TTM (YoY)-8.17%
EBITD / Share (TTM)$0.08
ROE (5Y Avg)-67.57%
Operating Margin (TTM)2.88%
Cash Flow / Share (Annual)$0.25
P/B Ratio1.43x
P/B Ratio (Quarterly)2.06x
Net Income / Employee (Annual)$-15,500
EV / Revenue (TTM)0.74x
Net Interest Coverage (TTM)-0.30x
ROA (TTM)-1.22%
EV / EBITDA (TTM)19.74x
EPS Incl Extra (Annual)$-0.08
Current Ratio (Annual)1.66x
Quick Ratio (Quarterly)1.45x
3-Month Avg Trading Volume0.93M
52-Week Price Return-62.02%
EV / Free Cash Flow (Annual)6.76x
Revenue / Employee (TTM)$483,100
Tangible BV / Share (Quarterly)$0.17
P/S Ratio (Annual)0.26x
Asset Turnover (Annual)0.60x
52-Week High$2.69
Operating Margin (5Y Avg)-12.96%
EPS Excl Extra (Annual)$-0.08
CapEx CAGR (5Y)6.21%
26-Week Price Return-58.95%
Quick Ratio (Annual)1.37x
13-Week Price Return-46.23%
Total Debt / Equity (Annual)5.97x
Current Ratio (Quarterly)1.79x
Enterprise Value$218.61M
Revenue / Share Growth (5Y)-7.28%
Asset Turnover (TTM)0.60x
Revenue / Employee (Annual)$490,700
Inventory Turnover (Annual)1.66x
Pretax Margin (Annual)-1.97%
Cash / Share (Annual)$1.82
3-Month Return Std Dev122.31%
Gross Margin (5Y Avg)63.48%
Net Income / Employee (TTM)$-9,900
ROE (Last FY)-15.59%
Net Interest Coverage (Annual)-0.35x
EPS Basic Excl Extra (Annual)$-0.08
P/FCF (TTM)2.44x
Receivables Turnover (TTM)14.14x
EV / Free Cash Flow (TTM)9.40x
Total Debt / Equity (Quarterly)6.23x
EPS Incl Extra (TTM)$-0.06
Receivables Turnover (Annual)12.18x
ROI (TTM)-1.43%
P/S Ratio (TTM)0.27x
Pretax Margin (5Y Avg)-33.84%
Revenue / Share (Annual)$2.38
Tangible BV / Share (Annual)$0.20
Price vs S&P 500 (52W)-86.39%
Year-to-Date Return-56.29%
5-Day Price Return-13.57%
EPS Normalized (Annual)$-0.08
ROA (5Y Avg)-8.65%
Net Profit Margin (Annual)-3.16%
Month-to-Date Return-21.48%
Cash Flow / Share (TTM)$-0.40
EBITD / Share (Annual)$0.01
Operating Margin (Annual)-0.90%
LT Debt / Equity (Annual)3.94x
P/CF (TTM)2.72x
ROI (5Y Avg)-10.20%
LT Debt / Equity (Quarterly)4.37x
EPS Basic Excl Extra (TTM)$-0.06
P/TBV (Quarterly)5.07x
P/B Ratio (Annual)2.90x
Inventory Turnover (TTM)1.71x
Pretax Margin (TTM)-1.20%
Book Value / Share (Annual)$0.48
Price vs S&P 500 (13W)-54.48%
Beta1.10x
P/FCF (Annual)2.44x
Revenue / Share (TTM)$2.32
ROE (TTM)-9.46%
52-Week Low$0.55
vGradeA
gGradeD
mGradeF
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.05est. -0.08
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.57
2.57
2.57
2.57
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SKINSkinHealth Systems Inc. Class A Common Stock | A | D | F | $0.61 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
The Beauty Health Company designs and manufactures aesthetic technology platforms for professional beauty treatments. Its brand portfolio includes Hydrafacial for skin resurfacing, SkinStylus for microneedling, and Keravive for scalp care, with revenue generated through device sales and recurring consumables.